Business description: TearLab Corporation

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Sales by Activity: TearLab Corporation

Fiscal Period: December 2019 (USD)

Diagnostic Kits / Equipment

22.66M

Geographical breakdown of sales: TearLab Corporation

Fiscal Period: December 2019 (USD)

United States

21.29M

Rest of the World

1.37M

Executive Committee: TearLab Corporation

Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Chief Tech/Sci/R&D Officer - 17/07/2009
Director of Finance/CFO 60 01/07/2022
Chief Tech/Sci/R&D Officer - 01/10/2006
Chief Tech/Sci/R&D Officer 73 -

Composition of the Board of Directors: TearLab Corporation

Director TitleAgeSince
Director/Board Member 58 09/07/2020
Chairman 68 09/12/2021
Director/Board Member 78 01/09/2004
Director/Board Member 62 -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Company details: TearLab Corporation

TearLab Corp., Inc.

940 South Kimball Avenue

76092, Southlake

+855-832-7522

http://www.tearlab.com
address TearLab Corporation

Glasses, Spectacles & Contact Lenses

Change 5-day change 1-year change 3-year change Capi.($)
+3.52%+4.85%-11.20%+14.59% 184B
+2.64%+4.44%+9.76%+37.33% 118B
+4.66%-0.36%-14.84%+9.63% 111B
+1.41%+6.80%-41.04%+6.45% 94.58B
+1.18%+1.41%-1.84%+74.13% 63.13B
-5.48%-5.08%-1.24%+63.86% 55.66B
+0.59%+1.27%+12.18%-22.28% 53.9B
+20.36%+16.41%-8.18%+58.26% 43.42B
+2.23%+4.24%+2.48%-8.32% 34.68B
Average +3.43%+0.06%-5.99%+25.96% 84.27B
Weighted average by Cap. +3.10%+0.24%-8.22%+23.80%
  1. Stock Market
  2. Stocks
  3. Stock
  4. Company TearLab Corporation